Pharmaceutical, Chemical & Biotech Litigation: Year In Review

As in previous years, 2015 brought a combination of expected and unexpected holdings by the Supreme Court and the Federal Circuit.

On the expected side of the ledger, the Supreme Court continued its pattern of reversing the Federal Circuit, this year regarding claim construction and induced infringement. Also, true to past history, the Federal Circuit on remand took the Supreme Court’s holdings setting forth new tests on both indefiniteness and claim construction, and reached the same result.

Read our detailed analysis of pivotal 2015 pharmaceutical, chemical, and biotech cases here.